Abstract

BackgroundComposite outcomes are increasingly being used in obstetric trials. The aim of this systematic review is to critically appraise the use of composite outcomes in obstetric RCTs with an intention of identifying limitations and providing potential solutions for future research.MethodsThe study protocol was prospectively registered. Medline, Embase, Cochrane Databases and www.clinicaltrials.gov were searched for randomized controlled trials (RCTs) published in English between 1999 and 2019, using search terms related to pregnancy and composite outcomes. Study eligibility criteria: RCTs involving an obstetric condition that reported on a composite outcome. Study appraisal and synthesis methods: Screening and data extraction were performed in duplicate, and a descriptive synthesis and critical appraisal of composite obstetric outcomes, is presented.ResultsOf the 4170 results screened, we identified 156 RCTs, reporting on 181 composite outcomes. Of these, 158 composite outcomes related to general morbidity and mortality, either exclusively maternal (n=20), fetal-neonatal [perinatal] (n=116) or maternal and perinatal (n=22) were included in the final analysis. Obstetric composite outcomes included between two and 16 components. Components that comprised these composite outcomes were often dissimilar in terms of severity and frequency of occurrence, unlikely to have similar relative risk reductions and sometimes unrelated to the study’s primary objective – important pre-requisites to consider while constructing composite outcomes. In addition, composite adverse obstetric outcomes often do not incorporate the perspectives of pregnant persons, embrace a holistic view of health or consider outcomes related to both members of the mother-fetus dyad.ConclusionsComposite outcomes are being increasingly used as primary outcomes in obstetric RCTs, based on which study conclusions are drawn and clinical recommendations made. However, there is a lack of consistency with regard to what components should be included within a composite adverse obstetric outcome and how these components should be measured. The use of novel research methods such as concept mapping may be able to address some of the limitations with the development of composite adverse obstetric outcomes, to inform future research.

Highlights

  • Composite outcomes are increasingly being used in obstetric trials

  • 264 full-texts were reviewed in detail which resulted in 156 Randomized controlled trial (RCT) that reported 181 composite outcomes that were included in the final analysis (Fig. 1)

  • The composite outcome was the primary outcome in 119 RCTs and the secondary outcome in 24 RCTs

Read more

Summary

Introduction

Composite outcomes are increasingly being used in obstetric trials. The aim of this systematic review is to critically appraise the use of composite outcomes in obstetric RCTs with an intention of identifying limitations and providing potential solutions for future research. In areas of medicine such as obstetrics, where serious clinical outcomes such as mortality and severe morbidity are very rare [1], composite endpoints such as a “composite adverse pregnancy outcome” are widely utilized in RCTs comparing the effectiveness of treatments. Composite outcomes are being widely used in obstetric RCTs, there is limited information on how the components of these composite outcomes are selected. The aim of this study was to critically appraise the use of composite outcomes in obstetric RCTs with an intention of identifying limitations and providing potential solutions and recommendations for future research

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call